International research finds quality and safety problems in hospitals throughout 13 countries

 

Philadelphia, PA, USA (March 20, 2012) – In one of the largest studies of its kind, a consortium of investigators from 13 countries led the University of Pennsylvania School of Nursing in the U.S. and the Catholic University of Leuven, Belgium in Europe, found that nurses who reported better working conditions in hospitals and less likelihood of leaving also had patients who were more satisfied with their hospital stay and rated their hospitals more highly. The study was released today in the current issue of the prestigious British Medical Journal.

 

The massive study, which in some countries involved every hospital, surveyed 61,168 bedside nurses and 131,318 patients in more than 1,000 hospitals in 13 countries over the course of three years, finding that in those hospitals with better work environments and fewer patients in each nurse’s workload, patient and nurses both reported higher standards of care and more satisfied patients.

 

"Patients in European and U.S. hospitals with better work environments were more likely to rate their hospital highly and to recommend their hospital" to others, wrote the study’s lead author, Linda H. Aiken, PhD, RN, a professor of nursing and sociology and director of the Center for Health Outcomes and Policy Research at the University of Pennsylvania School of Nursing.

 

Patient safety is also a concern in hospitals that have poor work environments and insufficient nurse staffing, said Walter Sermeus, professor at Catholic University of Leuven, Belgium, leader of the European consortium.

 

Nurses in Poland and Greece were three times more likely to give their hospitals a failing grade for safety than nurses in the U.S. and Norway. The majority of nurses in every country expressed a lack of confidence that hospital management would resolve problems in patient care.

 

Specifically the researchers found that:

 

  • High nurse burnout and job dissatisfaction were common among hospital nurses in Europe and the U.S.
  • On average, only 60 percent of patients were satisfied with their hospital care.
  • Those nurses reporting high levels of burnout (notably in Greece and England) also reported an intention to leave their current positions.
  • Each additional patient added to a nurse’s workload increased the odds of a nurse reporting poor or fair quality of care.
  • Patients were less satisfied with their hospital stay in those hospitals that had higher percentages of burnt out or dissatisfied nurses.

 

Policy implications for the findings suggest that despite the differences among the healthcare systems studied, particularly in terms of both organization and financing, all countries encountered problems of "hospital quality, safety, and nurse burnout and dissatisfaction." Many European nurses report they intend to leave their hospital positions, from 19 percent in The Netherlands to nearly half of all nurses (49 percent) in Finland and Greece, leading the researchers to ponder the potential for a worsening shortage of nurses.

 

A significantly lower proportion of nurses in the U.S. (14 percent) reported their intentions to leave their current positions, possibly due to increased efforts in the U.S. to improve hospital nurse staffing levels. Having fewer patients per nurse has been linked to better outcomes for patients, including lower rates of death following everyday surgeries. Nearly 7 percent or 400 in the hospitals in the U.S. have achieved "magnet status," so-called due to its ability to attract and retain nurses because of good work environments. No hospital in Europe has a similar "magnet" designation.

 

 

The study, conducted with a 3 million euro grant from the European Commission with additional funding from the National Institute of Nursing Research of the National Institutes of Health in the U.S., investigated hospital quality and safety of care in Belgium, England, Finland, Ireland, Germany, Greece, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, and the U.S.

 

The full article can be found at http://www.bmj.com/content/344/bmj.e1717

 

 


University of Pennsylvania School of Nursing, 20.03.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…